INT67783

Context Info Confidence 0.37 First Reported 1996 Last Reported 2010 Negated 0 Speculated 0 Reported most in Body Documents 3 Total Number 3 Disease Relevance 1.23 Pain Relevance 0.50

cytosol (LARS) ligase activity (LARS) cytoplasm (LARS)

LARS (Homo sapiens)

Pain Link Frequency Relevance Heat Cauda equina syndrome 1 92.76 Pain 18 88.44 imagery 3 78.60 Sciatica 2 69.64 spinal stenosis 1 43.72 Dermatone 2 41.68 Osteoarthritis 2 5.00

Disease Link Frequency Relevance Heat Syndrome 42 100.00 Polyradiculopathy 1 92.76 Paresis 1 90.76 Phobia 4 89.76 Pain 18 88.44 Frailty 1 73.92 Nerve Root Compression 3 69.64 Synovitis 9 68.60 Rupture 21 67.64 Spinal Stenosis 1 43.72

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

Also absent is any research on the cost effectiveness of LARS when compared to other traditional techniques.

Negative_regulation (effectiveness) of LARS

1) Confidence 0.37 Published 2010 Journal Sports Med Arthrosc Rehabil Ther Technol Section Body Doc Link PMC3016369 Disease Relevance 0.14 Pain Relevance 0

There are no strategies for the primary or secondary prevention of LRS that have demonstrated their efficacy.

Negative_regulation (prevention) of LRS associated with syndrome

2) Confidence 0.35 Published 1996 Journal Ned Tijdschr Geneeskd Section Abstract Doc Link 9026741 Disease Relevance 0.65 Pain Relevance 0.25

Costs will be calculated and include LRS related sickness absence from work, medical consumption (i.e. medication use, additional therapies, visits to health care providers), out-of-pocket expenses and paid help.

Negative_regulation (absence) of LRS associated with syndrome

3) Confidence 0.22 Published 2004 Journal BMC Musculoskelet Disord Section Body Doc Link PMC534096 Disease Relevance 0.44 Pain Relevance 0.25

General Comments

This test has worked.